Comparison of von Willebrand factor antigen, von Willebrand factor-cleaving protease and protein S in blood components used for treatment of thrombotic thrombocytopenic purpura.
about
The influence of riboflavin photochemistry on plasma coagulation factorsIs solvent/detergent plasma better than standard fresh-frozen plasma? A systematic review and an expert consensus documentDoes cryosupernatant plasma improve outcome in thrombotic thrombocytopenic purpura? No answer yet.Coagulation factor levels in cryosupernatant prepared from plasma treated with amotosalen hydrochloride (S-59) and ultraviolet A light.The pathogenicity of von Willebrand factor in thrombotic thrombocytopenic purpura: reconsideration of treatment with cryopoor plasma.Normal levels of ADAMTS13 and factor H are present in the pharmaceutically licensed plasma for transfusion (Octaplas) and in the universally applicable plasma (Uniplas) in development.Thrombotic thrombocytopenic purpura: a thrombotic disorder caused by ADAMTS13 deficiencyCryosupernatant and solvent detergent fresh-frozen plasma (Octaplas) usage at a single centre in acute thrombotic thrombocytopenic purpura.ADAMTS13 unbound to larger von Willebrand factor multimers in cryosupernatant: implications for selection of plasma preparations for thrombotic thrombocytopenic purpura treatment.Safety and efficacy of cryoprecipitate-poor plasma as a replacement fluid for therapeutic plasma exchange in thrombotic thrombocytopenic purpura: a single center retrospective evaluation.Pathogenicity of Anti-ADAMTS13 Autoantibodies in Acquired Thrombotic Thrombocytopenic Purpura.Diagnosis and management of thrombotic thrombocytopenic purpura (TTP) in Australia: findings from the first 5 years of the Australian TTP/thrombotic microangiopathy registry.Efficacy and Safety Profile of Solvent/Detergent Plasma in the Treatment of Acute Thrombotic Thrombocytopenic Purpura: A Single-Center ExperienceVirus-inactivated plasma - Plasmasafe: a one-year experienceRecommendations from the Tuscan Transfusion System on the appropriate use of solvent/detergent-inactivated fresh-frozen plasmaRecommendations for the transfusion of plasma and platelets.A comparison of methods of pathogen inactivation of FFP.Solvent/detergent plasma: pharmaceutical characteristics and clinical experience.Evaluating the impact of the ABO blood group on the clinical outcome of thrombotic thrombocytopenic purpura associated with severe ADAMTS13 deficiency.Thrombin Generation Capacity of Methylene Blue-Treated Plasma Prepared by the Theraflex MB Plasma System.Coagulation factor content of plasma produced from whole blood stored for 24 hours at ambient temperature: results from an international multicenter BEST Collaborative study.Quality and safety of fresh-frozen plasma inactivated and leucoreduced with the Theraflex methylene blue system including the Blueflex filter: 5 years' experience.
P2860
Q24614152-B1351F94-B633-442A-94E3-8EB12F0FF577Q26748355-392BDF85-AD1F-47BD-9A4A-0AEAE59F9A7FQ33365640-3E53E8AF-4E93-43DE-AF21-8DF65B830A68Q33368173-75A61186-1818-411B-BD93-939CD2BFF3ADQ33369832-FF1A2441-75F5-4D86-A36C-1E75361129F8Q33374478-45E93B29-E1DA-4C49-AECB-C4F3FA901DD4Q33376071-DB6E1598-F323-449C-8C27-CB33E11F818AQ33376161-D65DE9FA-AC1D-4C18-AEDE-9331DB019D77Q33406892-40ADA435-3CFC-4C2E-8CD7-593A64B5D3A5Q33415693-4A186882-F6ED-4212-89F1-BAC5078A5CBAQ33426377-DE42EA2D-C1AB-46BF-9DFB-941DD2261C0AQ33426823-79AD0023-648B-4FDF-85E2-D21CFCBEE3C4Q34038164-318F993F-2C8E-4560-9178-25490FF62359Q36874269-F1248082-7BE4-433C-ABC0-B824B0492135Q37062415-ABC3BAEB-EBD3-49AF-9449-7CA1910FDB32Q37209117-3C8EB713-BC59-4E86-8977-0589BD01BB17Q37776318-EFC4563A-04B6-4DD3-8B74-4AD132B4063EQ38213153-C921F4E2-2A21-4A96-A452-7AC15C23F407Q38736033-7391AE5E-3DD3-4273-8894-9856500A9D00Q41869417-18B72101-D80E-4AE4-94DC-9FB7D5F81C44Q43744630-4506391F-3F29-4FE0-BC77-D2EFC7324574Q50469599-61230793-24E6-4DEA-A918-164F3CC187AC
P2860
Comparison of von Willebrand factor antigen, von Willebrand factor-cleaving protease and protein S in blood components used for treatment of thrombotic thrombocytopenic purpura.
description
2004 nî lūn-bûn
@nan
2004 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Comparison of von Willebrand f ...... otic thrombocytopenic purpura.
@ast
Comparison of von Willebrand f ...... otic thrombocytopenic purpura.
@en
type
label
Comparison of von Willebrand f ...... otic thrombocytopenic purpura.
@ast
Comparison of von Willebrand f ...... otic thrombocytopenic purpura.
@en
prefLabel
Comparison of von Willebrand f ...... otic thrombocytopenic purpura.
@ast
Comparison of von Willebrand f ...... otic thrombocytopenic purpura.
@en
P2093
P2860
P1433
P1476
Comparison of von Willebrand f ...... otic thrombocytopenic purpura.
@en
P2093
P2860
P356
10.1111/J.0958-7578.2004.00478.X
P577
2004-02-01T00:00:00Z